The present invention provides genetically altered mammalian embryonic stem cells, their living descendent progeny having an altered genomic DNA, and therapeutic methods using these cells for improving cardiac function in a living subject after myocardial infarction. The genetically altered embryonic...http://www.google.fr/patents/US6607720?utm_source=gb-gplus-shareBrevet US6607720 - Genetically altered mammalian embryonic stem cells, their living progeny, and their therapeutic application for improving cardiac function after myocardial infarction
Genetically altered mammalian embryonic stem cells, their living progeny ...
